Oppenheimer & Co.

AI Will Drive 25% Of GDP In 10 Years, Says Analyst: Which Company Will Emerge The Winner?

MindMed's Shares Drop 50% On $30M Public Offering

Leafly Cannabis Info Platform Goes Public Via Deal With Merida Merger Corp, The Combined Company Equity Projected At $532M

MindMed's Shares Drop 50% On $30M Public Offering

Leafly Cannabis Info Platform Goes Public Via Deal With Merida Merger Corp, The Combined Company Equity Projected At $532M

Oppenheimer NAREIT Preview: A Bullish Outlook On Real Estate

Oppenheimer: 25% Upside For Small-Cap REIT Bluerock Residential

Oppenheimer NAREIT Preview: A Bullish Outlook On Real Estate

Oppenheimer: 25% Upside For Small-Cap REIT Bluerock Residential

Solid Q1 For Morgan Stanley, But Oppenheimer Says Not Big Enough To Move The Needle

Oppenheimer And Zillow: Model Adjusted Amid Trulia Acquisition, Shares Rebounding

Oppenheimer & Co. Recent News

UPDATE: Oppenheimer Raises Price Target On Chipotle Mexican Grill, Inc.

U.S. Oil Refining Eyes Big Expansion Amid Shale Spike

Do Recent J.C. Penney Share Prices Reflect Investor Optimism or False Hope?

UPDATE: Oppenheimer Initiates Fusion-io at Perform Rating on Current Competitive Advantage

Oppenheimer Maintains Corning at Outperform on Long-Term Segment Display Positivity

UPDATE: Oppenheimer Raises Gilead PT on Promising Oncology Pipeline

UPDATE: Oppenheimer Raises Semtech PT to $41 Following Gennum Acquisition

Oppenheimer Maintains Outperform on Nvidia

Oppenheimer Maintains Outperform on Apple

UPDATE: Oppenheimer Upgrades Linear Technology to Outperform, Establishes $36 PT

Oppenheimer Has Perform on RRsat Global Communications Networks

Oppenheimer Outperform on Netease.com

Oppenheimer Has Perform on NetApp

Oppenheimer Has Perform on Vistaprint

Oppenheimer Has Perform on Simcere Pharmaceutical Group

Oppenheimer Outperform on AEterna Zentaris

Oppenheimer Outperform on Mindray Medical

Oppenheimer Outperform on Kodiak Oil & Gas

Oppenheimer Outperform on Globe Specialty Metals

Oppenheimer Outperform on MedAssets

Oppenheimer Outperform on Amedisys

Oppenheimer Outperform on Generac

UPDATE: Oppenheimer Lowering Price Target on OpenTable